BioMarin Pharmaceutical Inc. (BMRN) vs ImmunityBio, Inc. (IBRX)
A side-by-side comparison of BioMarin Pharmaceutical Inc. and ImmunityBio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BMRN
BioMarin Pharmaceutical Inc.
$56.42HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT
IBRX
ImmunityBio, Inc.
$9.87HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT
Total return — BMRN vs IBRX
growth of $100 · dividends reinvested · last 10yBMRN -39.5% (-4.9%/yr)IBRX +41.8% (+3.6%/yr)IBRX compounded faster over this window
BMRN IBRX
BMRN vs IBRX: by the numbers
- •BMRN is the larger company ($10.91B vs $10.34B market cap).
- •BMRN is profitable (2.14% net margin) while IBRX runs a net loss (-598.56%).
- •IBRX grew revenue faster over the past five years (202.97% vs 12.19% CAGR).
Metrics side by side
Valuation
| Metric | BMRN | IBRX |
|---|---|---|
| P/E ratio | 144.67 | N/A |
| P/S ratio | 3.20 | 62.35 |
| P/B ratio | 1.73 | N/A |
| EV / EBITDA | 33.39 | N/A |
| FCF yield | 6.72% | N/A |
Profitability
| Metric | BMRN | IBRX |
|---|---|---|
| Gross margin | 75.55% | 94.63% |
| Operating margin | 16.56% | -226.00% |
| Net margin | 2.14% | -598.56% |
| ROE | 1.15% | N/A |
| ROIC | 1.40% | -45.63% |
Growth (annualized)
| Metric | BMRN | IBRX |
|---|---|---|
| Revenue CAGR (5Y) | 12.19% | 202.97% |
| EPS CAGR (5Y) | -17.46% | N/A |
| FCF CAGR (5Y) | 33.84% | N/A |
| Total return CAGR (5Y) | -5.59% | 0.39% |
Frequently asked
- Which has grown faster, BMRN or IBRX?
- Over the past five years, IBRX grew revenue faster — BMRN at a 12.19% CAGR versus IBRX at 202.97%.
- Is BMRN or IBRX more profitable?
- BMRN runs the higher net margin — BMRN at 2.14% versus IBRX at -598.56%.
- How have BMRN and IBRX total returns compared?
- Over the past 10 years, BMRN delivered -4.98% and IBRX delivered 2.95% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
BioMarin Pharmaceutical P/E ratioBioMarin Pharmaceutical ROEImmunityBio ROEBioMarin Pharmaceutical operating marginImmunityBio operating marginBioMarin Pharmaceutical revenue growthImmunityBio revenue growthBioMarin Pharmaceutical free cash flowImmunityBio free cash flow
BioMarin Pharmaceutical & ImmunityBio appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.